JF
IMRX icon

Jump Financial’s Immuneering IMRX Stock Holding History

Jump Financial’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.6K Buy
+12,250
New +$62.8K ﹤0.01% 1778
2022
Q2 		– Sell
-19,300
Closed -$125K – 1804
2022
Q1 		$125K Buy
+19,300
New +$185K 0.01% 1387

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jump Financial's IMRX Position: Q1 2026 in Review

Jump Financial opened a new position in Immuneering (IMRX) in Q1 2026: 12,250 shares worth $64.6K. The stake represents ﹤0.01% of the portfolio and ranks #1778 among its holdings. This is a return to the name: Jump Financial previously reported a position in IMRX as recently as Q1 2022.

Jump Financial first reported a position in IMRX in Q1 2022 and has held it in 2 quarters since. The position peaked at $125K in Q1 2022. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Jump Financial held 12,250 shares of Immuneering worth $64.6K as of Q1 2026.
  • Immuneering was a new Jump Financial position in Q1 2026.
  • Immuneering made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1778 holding.
  • Jump Financial first reported a position in Immuneering in Q1 2022 and has held it in 2 quarters since.
  • Jump Financial's Immuneering position peaked at $125K in Q1 2022.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.